Cargando…
Predicting survival in malignant pleural mesothelioma using routine clinical and laboratory characteristics
INTRODUCTION: The prognosis of malignant pleural mesothelioma (MPM) is poor, with a median survival of 8–12 months. The ability to predict prognosis in MPM would help clinicians to make informed decisions regarding treatment and identify appropriate research opportunities for patients. The aims of t...
Autores principales: | Gunatilake, Samal, Lodge, David, Neville, Daniel, Jones, Thomas, Fogg, Carole, Bassett, Paul, Begum, Selina, Kerley, Sumita, Marshall, Laura, Glaysher, Sharon, Elliott, Scott, Stores, Rebecca, Bishop, Lesley, Chauhan, Anoop |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797245/ https://www.ncbi.nlm.nih.gov/pubmed/33414260 http://dx.doi.org/10.1136/bmjresp-2019-000506 |
Ejemplares similares
-
Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study
por: van Kooten, Job P, et al.
Publicado: (2022) -
The SENSOR Study: Protocol for a Mixed-Methods Study of Self-Management Checks to Predict Exacerbations of Pseudomonas Aeruginosa in Patients with Long-Term Respiratory Conditions
por: Roberts, Claire, et al.
Publicado: (2017) -
A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): study protocol for a randomised controlled trial
por: Gunatilake, Samal, et al.
Publicado: (2014) -
Communication of a mesothelioma diagnosis: developing recommendations to improve the patient experience
por: Taylor, Bethany Hope, et al.
Publicado: (2019) -
Understanding clinical decision-making in mesothelioma care: a mixed methods study
por: Henshall, Catherine, et al.
Publicado: (2022)